Clinical outcomes of pomalidomide‐based and daratumumab‐based therapies in patients with relapsed/refractory multiple myeloma: A real‐world cohort study in China.
Saved in:
| Title: | Clinical outcomes of pomalidomide‐based and daratumumab‐based therapies in patients with relapsed/refractory multiple myeloma: A real‐world cohort study in China. |
|---|---|
| Authors: | Han, Xiaoyan1 (AUTHOR), Jiang, Xincheng1 (AUTHOR), He, Jingsong1 (AUTHOR), Zheng, Gaofeng1 (AUTHOR), Xiong, Yaqin1 (AUTHOR), Wen, Yanling1 (AUTHOR), Yang, Yang1 (AUTHOR), He, Donghua1 (AUTHOR), Chen, Qingxiao1 (AUTHOR), Zhao, Yi1 (AUTHOR), Li, Yi1 (AUTHOR), Wu, Wenjun1 (AUTHOR), Cai, Zhen1,2 (AUTHOR) caiz@zju.edu.cn |
| Source: | Cancer Medicine. May2024, Vol. 13 Issue 9, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
